Mankind Pharma’s wholly owned subsidiary (WOS) -- Mankind Lifesciences (MLS) has acquired the remaining 10% stake of Upakarma Ayurveda (Upakarma) from Kaushcorp Media LLP through a share purchase agreement (SPA) for Rs 75 lakh (payable in two tranches as per SPA) on June 2, 2026. MLS is already holding 90% stake in Upakarma.
This acquisition will enable the company to achieve better operational efficiencies through streamlined processes. Consequent to this acquisition, Upakarma has become a WOS of MLS and a step-down WOS of the company.
Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
